View in EDS PDF Full Text

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Saved in:
Bibliographic Details
Title: Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.
Authors: Simpson-Abelson MR; The State University of New York at Buffalo, Department of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, Buffalo, NY, USA., Loyall JL, Lehman HK, Barnas JL, Minderman H, O'Loughlin KL, Wallace PK, George TC, Peng P, Kelleher RJ Jr, Odunsi K, Bankert RB
Source: Cancer immunity [Cancer Immun] 2013 Jul 15; Vol. 13, pp. 14. Date of Electronic Publication: 2013 Jul 15 (Print Publication: 2013).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Cancer Research Institute Country of Publication: United States NLM ID: 101119871 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1424-9634 (Electronic) Linking ISSN: 14249634 NLM ISO Abbreviation: Cancer Immun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23882159
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Simpson-Abelson+MR%22">Simpson-Abelson MR</searchLink>; The State University of New York at Buffalo, Department of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Loyall+JL%22">Loyall JL</searchLink><br /><searchLink fieldCode="AU" term="%22Lehman+HK%22">Lehman HK</searchLink><br /><searchLink fieldCode="AU" term="%22Barnas+JL%22">Barnas JL</searchLink><br /><searchLink fieldCode="AU" term="%22Minderman+H%22">Minderman H</searchLink><br /><searchLink fieldCode="AU" term="%22O'Loughlin+KL%22">O'Loughlin KL</searchLink><br /><searchLink fieldCode="AU" term="%22Wallace+PK%22">Wallace PK</searchLink><br /><searchLink fieldCode="AU" term="%22George+TC%22">George TC</searchLink><br /><searchLink fieldCode="AU" term="%22Peng+P%22">Peng P</searchLink><br /><searchLink fieldCode="AU" term="%22Kelleher+RJ+Jr%22">Kelleher RJ Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Odunsi+K%22">Odunsi K</searchLink><br /><searchLink fieldCode="AU" term="%22Bankert+RB%22">Bankert RB</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101119871%22">Cancer immunity</searchLink> [Cancer Immun] 2013 Jul 15; Vol. 13, pp. 14. <i>Date of Electronic Publication: </i>2013 Jul 15 (<i>Print Publication: </i>2013).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cancer+Research+Institute%22">Cancer Research Institute </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101119871 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1424-9634 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214249634%22">14249634 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23882159
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 14
    Titles:
      – TitleFull: Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Simpson-Abelson MR
      – PersonEntity:
          Name:
            NameFull: Loyall JL
      – PersonEntity:
          Name:
            NameFull: Lehman HK
      – PersonEntity:
          Name:
            NameFull: Barnas JL
      – PersonEntity:
          Name:
            NameFull: Minderman H
      – PersonEntity:
          Name:
            NameFull: O'Loughlin KL
      – PersonEntity:
          Name:
            NameFull: Wallace PK
      – PersonEntity:
          Name:
            NameFull: George TC
      – PersonEntity:
          Name:
            NameFull: Peng P
      – PersonEntity:
          Name:
            NameFull: Kelleher RJ Jr
      – PersonEntity:
          Name:
            NameFull: Odunsi K
      – PersonEntity:
          Name:
            NameFull: Bankert RB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2013 Jul 15
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1424-9634
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Cancer immunity
              Type: main
ResultId 1